🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

6 Gram(s) Serving Size
45 Servings
Other Combinations Product Type
33% Evidence Coverage

Supplement Facts — Evidence Check

Calories
10 mg (50% DV)
✅ Within RDA (0.7× RDA of 14 mg) 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 10mg UL 35mg
10 mg (500% DV)
📊 7.7× RDA — above typical dose (UL: 100 mg) 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 10mg UL 100mg
Potassium
67 mg (2% DV)
PurplEAA Complex
7000 mg
PurplEndurance Complex
2700 mg

Other Ingredients

Citric Acid Natural and Artificial Grape flavor Silicon Dioxide Acesulfame Potassium Sucralose Bilberry extract

Label Claims — Verification

All Other
Structure/Function
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions for Usage: Combine 1-2 scoops of PURPLE WRAATH(TM) with 20-40 oz. of water, and consume it pre-workout or over an extended period of time (pre-workout, during your workout, and post-workout). Shake well before drinking. For best results, PURPLE WRAATH(TM) should be used in conjunction with other Controlled Labs products, with at least 1-2 gallons of water per day, and a high protein/moderate carbohydrate diet. For more details on optimizing your results, please see www.ControlledLabs.com

Initial (First Serving) Instructions: To assess your individual tolerance to the ergogenic matrix, combine 1/2 scoop of PURPLE WRAATH(TM) with 4 oz. of water and consume it before, during and/or after your workout. Shake well before drinking.

⚠️ Warnings & Precautions

Keep out of the reach of children.

Do not purchase if safety seal is broken.

Warnings: The ergogenic matrix may cause a slight tingling in some. This is a natural characteristic.

You should not take this product if you have any prior medical condition, including diabetes or high blood pressure. Consult your doctor before using this product.

Additional Information

ERGOGENIC ESSENTIAL AMINO ACID MATRIX

Juicy Grape Flavor

Product Details

UPC / SKU 8 95328 00144 6
DSLD Entry Date 2011-11-25
Product Type Other Combinations
Form Powder
DSLD ID 2635
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →